Treatment of unscheduled bleeding in continuous oral contraceptive users with doxycycline: A randomized controlled trial

Obstetrics and Gynecology

Volumn 115, Issue 6, 2010, Pages 1141-1149

  Kaneshiro, Bliss ^a   Edelman, Alison ^a   Carlson, Nichole ^a   Morgan, Kristin ^a   Nichols, Mark ^a   Jensen, Jeffrey ^a  

^a Department of Obstetrics and Gynecology ^*

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; PLACEBO;

ACNE; ADULT; ARTICLE; BLEEDING TIME; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSMENORRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOOD CHANGE; MULTIPLE CYCLE TREATMENT; NAUSEA; ORAL CONTRACEPTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SIDE EFFECT; SPOTTING; TREATMENT DURATION; TREATMENT OUTCOME; VAGINA BLEEDING; VAGINA CANDIDIASIS;

CONTRACEPTIVES, ORAL, COMBINED; DOUBLE-BLIND METHOD; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MATRIX METALLOPROTEINASES; METRORRHAGIA; PATIENT SATISFACTION; YOUNG ADULT;

EID: 77952969989     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181e0119c     Document Type: Article

References (20)

1. Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 2003;101:653-661
2. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003;68: 89-96.
3. Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod 1996;11(suppl 2):124-133
4. Galant C, Berliere M, Dubois D, Verougstraete JC, Charles A, Lemoine P, et al. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endo-metrial bleeding. Am J Pathol 2004;165:83-94.
5. Chegini N, Rhoton-Vlasak A, Williams RS. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and-4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorg-estrel implants who experience irregular uterine bleeding. Fertil Steril 2003;80:564-570
6. Vincent AJ, Zhang J, Ostor A, Rogers PA, Affandi B, Kovacs G, et al. Matrix metalloproteinase-1 and-3 and mast cells are present in the endometrium of women using progestin-only contraceptives. Hum Reprod 2000;15:123-130
7. Vincent AJ, Malakooti N, Zhang J, Rogers PA, Affandi B, Salamonsen LA. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B). Hum Reprod 1999;14: 807-815
8. Salamonsen LA, Zhang J, Hampton A, Lathbury L. Regulation of matrix metalloproteinases in human endometrium. Hum Reprod 2000;15(suppl 3):112-119
9. Marbaix E, Kokorine I, Henriet P, Donnez J, Courtoy PJ, Eeckhout Y. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem J 1995; 305(pt 3):1027-1030
10. Burns FR, Stack MS, Gray RD, Paterson CA. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 1989;30:1569-1575
11. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201-222
12. Mishell DR Jr, Guillebaud J, Westhoff C, Nelson AL, Kaunitz AM, Trussell J, et al. Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials. Contraception 2007;75:11-15
13. Edelman AB, Koontz SL, Nichols MD, Jensen JT. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given? Obstet Gynecol 2006;107:657-665
14. Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception 2006;74:439-445
15. Murphy AA, Zacur HA, Charache P, Burkman RT. The effect of tetracycline on levels of oral contraceptives. Am J Obstet Gynecol 1991;164(1 pt 1):28-33.
16. Neely JL, Abate M, Swinker M, D'Angio R. The effect of doxycycline on serum levels of ethinyl estradiol, norethin-drone, and endogenous progesterone. Obstet Gynecol 1991; 77:416-420
17. Weisberg E, Hickey M, Palmer D, O'Connor V, Salamonsen LA, Findlay JK, et al. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 2006;21:295-302.
18. Zhao S, Choksuchat C, Zhao Y, Ballagh SA, Kovalevsky GA, Archer DF. Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant. Contraception 2009;79:469-478
19. Kaitu'u TJ, Shen J, Zhang J, Morison NB, Salamonsen LA. Matrix metalloproteinases in endometrial breakdown and repair: functional significance in a mouse model. Biol Reprod 2005;73:672-680
20. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986;34:253-260